Inventor · disambiguated record
Kayla J. Temple
Also filed as: TEMPLE KAYLA · TEMPLE KAYLA J
12 granted patents·10 pending applications·25 citations·filing 2015–2025
87Inventor score
Files withUNIV VANDERBILT22
Top patents by PatentIndex Score
22 records- 0195US11820757B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2022·Granted Nov 21, 2023·5 cites·20 claims
- 0293US11884676B2Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2023·Granted Jan 30, 2024·4 cites·30 claims
- 0390US11352344B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2018·Granted Jun 7, 2022·4 cites·19 claims
- 0490US11299481B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2018·Granted Apr 12, 2022·5 cites·20 claims
- 0585US12448380B2Positive modulators of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2024·Granted Oct 21, 2025·0 cites·8 claims
- 0684US12344608B2Positive modulators of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2024·Granted Jul 1, 2025·0 cites·7 claims
- 0783US11225484B2Substituted octahydropyrrolo[3,4-b]pyrroles as antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2018·Granted Jan 18, 2022·4 cites·18 claims
- 0883US10927126B2Positive allosteric modulators of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2017·Granted Feb 23, 2021·2 cites·28 claims
- 0971US2025263417A1Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2025·Application pending·0 cites
- 1069US9572794B2Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonistsUNIV VANDERBILT·Filed 2015·Granted Feb 21, 2017·1 cites·27 claims
- 1167US12331055B2Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2021·Granted Jun 17, 2025·0 cites·45 claims
- 1265US12139498B1Positive allosteric modulators of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2024·Granted Nov 12, 2024·0 cites·30 claims
- 1359US2025026752A1Positive allosteric modulators of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1459US2025002507A17,8-dihydro-5h-1,6-naphthyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 for treating neurological and psychiatric disordersUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1559US2025101041A1Positive allosteric modulators of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2023·Application pending·0 cites
- 1659US2025230155A17,8-dihydro-5h-1,6-naphthyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 for treating neurological and psychiatric disordersUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1756US2024390350A1Phenyl core compounds as mglu5 negative allosteric modulators and methods of making and using the sameUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1854US2023183237A1Competitive and noncompetitive inhibitors of the muscarinic acetylcholine receptor m5UNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 1953US2025026743A1Heteroaryl-linked analogs as mglu5 negative allosteric modulators and methods of making and using the sameUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 2047US2023150986A1Antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2020·Application pending·0 cites
- 2139US9963466B2Substituted 5-membered heterocyclic analogs as protease activated receptor 4 (PAR-4) antagonistsUNIV VANDERBILT·Filed 2017·Granted May 8, 2018·0 cites·25 claims
- 2236US2019119300A1Substituted and fused 6-membered protease activated receptor 4 (par-4) antagonistsUNIV VANDERBILT·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kayla J. Temple files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →